mgheaderbig
mgheaderbig

Advances in technology have improved healthcare providers' ability to rapidly diagnose patients at the point of care, screen for common conditions, and provide a variety of effective treatment options. Providers need to be aware of what innovations are available - or will become available in the near future. It is the purpose of Medgizmos to educate and inform healthcare providers regarding the latest and greatest technologies.

Slide 2

Latest Reviews

Image is not available
Connected Technology

ScopeAround Wifi Otoscope, new inexpensive digital otoscope!

Image is not available
Medical Devices

Check My Ear
Acoustic Otoscope

Image is not available
Software/Applications

Scoliometer application quantifies scoliosis via a smartphone!

Slide 2

Latest Interviews/Webinars

Image is not available
Interview

Outcome Referrals
Dr. David Kraus

Image is not available
Webinar

Plusoptix Vision Screening
Webinar

Slide 3

Subscribe to receive notifications of our latest posts.

Slide 3

View our Spring/Summer 2021 Newsletter

Slide 3

New! Visit Our Podcast Page

Slide 3

New! Visit MDMtool.org

previous arrow
next arrow

Navigation

Home page sections include recent video reviews, a searchable list of all posts, and a list of post pages organized by topic.

Medgizmos

Is the “virtual medical home” of Andrew J. Schuman MD, who has been writing about medical technology and medical practice for over 30 years!

Update

May 28, 2022:  MDMtool.org online! Vision Screening Webinar online!  Acoustic Otoscope review  online.

PlusOptix Vision Screening Webinar

Amblyopia is one of the most common visual problems of childhood, occurring in 2.5 % of children. It is defined as poor vision caused by abnormal development of visual areas of the brain; if undetected and untreated it can lead to permanent vision impairment.

Unfortunately, less than 40 % of children are screened for this condition. Causes of amblyopia include strabismus (misalignment of eyes), anisometropia (inequality of vision of both eyes because of refractive errors or astigmatism), cataracts, ptosis, or other factors. Because children do not complain of problems with visual acuity, and affected eyes often appear normal, amblyopia can easily go undetected unless a child has vision screening done routinely at health maintenance examinations.

Vision screening in children aged younger than 3 years in a medical office can be challenging because few children this age can be screened with a vision chart. From age 3 to 5 years, screening is possible with Snellen charts, Tumbling E charts, or picture tests such as Allen Visual Acuity Cards, but this is time consuming and can lead to inconsistent or erroneous results. According to the latest 2016 guidelines Screening instruments detect amblyopia, high refractive error, and strabismus. I recommend that  Instrument-based screening  should be performed at age two and repeated at each annual preventive medicine encounter through 7 years of age.

Amblyopia remains treatable until age 7 years, with rapid decline of effective treatment after age 5 years. The goal of vision screening in infants and young children, therefore, must be the early detection of high severity (magnitude) amblyopia risk factors (ARFs), including moderate or severe astigmatism, anisometropic myopia, high hyperopia, severe strabismus, and opacities in the visual axis, including retinoblastoma or other ocular entities that cause opacities that interfere with transmission of light to and from the retina.This webinar, sponsored by Plusoptix, details how screening with Plusoptix photoscreeners can facilitate identification of children at risk for amblyopia who should be seen by an optometrist or ophthalmologist for diagnosis and treatment. It also describes a pilot study demonstrating that if a child who refers on vision screening is given an appointment with a vision specialist before departing the pediatrician’s office, the success of achieving a completed diagnostic exam will exceed 90%!

Subscribe

Subscribe

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!